Logo image of PODD

INSULET CORP (PODD) Stock Fundamental Analysis

NASDAQ:PODD - Nasdaq - US45784P1012 - Common Stock - Currency: USD

246.8  -3.93 (-1.57%)

After market: 247 +0.2 (+0.08%)

Fundamental Rating

7

Overall PODD gets a fundamental rating of 7 out of 10. We evaluated PODD against 190 industry peers in the Health Care Equipment & Supplies industry. PODD scores excellent points on both the profitability and health parts. This is a solid base for a good stock. PODD is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make PODD suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year PODD was profitable.
In the past year PODD had a positive cash flow from operations.
PODD had positive earnings in each of the past 5 years.
PODD had a positive operating cash flow in 4 of the past 5 years.
PODD Yearly Net Income VS EBIT VS OCF VS FCFPODD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

The Return On Assets of PODD (13.55%) is better than 95.26% of its industry peers.
With an excellent Return On Equity value of 34.52%, PODD belongs to the best of the industry, outperforming 98.95% of the companies in the same industry.
PODD has a Return On Invested Capital of 9.49%. This is amongst the best in the industry. PODD outperforms 91.58% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PODD is in line with the industry average of 7.68%.
The 3 year average ROIC (6.40%) for PODD is below the current ROIC(9.49%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.55%
ROE 34.52%
ROIC 9.49%
ROA(3y)7.24%
ROA(5y)4.58%
ROE(3y)21.22%
ROE(5y)13.56%
ROIC(3y)6.4%
ROIC(5y)5.42%
PODD Yearly ROA, ROE, ROICPODD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

PODD has a better Profit Margin (20.19%) than 93.68% of its industry peers.
In the last couple of years the Profit Margin of PODD has grown nicely.
The Operating Margin of PODD (14.91%) is better than 85.26% of its industry peers.
In the last couple of years the Operating Margin of PODD has grown nicely.
PODD has a Gross Margin of 69.79%. This is in the better half of the industry: PODD outperforms 78.42% of its industry peers.
PODD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.91%
PM (TTM) 20.19%
GM 69.79%
OM growth 3Y9.15%
OM growth 5Y17.1%
PM growth 3Y136.37%
PM growth 5Y66.64%
GM growth 3Y0.65%
GM growth 5Y1.41%
PODD Yearly Profit, Operating, Gross MarginsPODD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PODD is still creating some value.
PODD has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, PODD has more shares outstanding
Compared to 1 year ago, PODD has an improved debt to assets ratio.
PODD Yearly Shares OutstandingPODD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PODD Yearly Total Debt VS Total AssetsPODD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

PODD has an Altman-Z score of 7.09. This indicates that PODD is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.09, PODD belongs to the top of the industry, outperforming 87.37% of the companies in the same industry.
PODD has a debt to FCF ratio of 4.70. This is a neutral value as PODD would need 4.70 years to pay back of all of its debts.
The Debt to FCF ratio of PODD (4.70) is better than 81.58% of its industry peers.
PODD has a Debt/Equity ratio of 1.08. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.08, PODD is doing worse than 75.79% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 4.7
Altman-Z 7.09
ROIC/WACC1.09
WACC8.71%
PODD Yearly LT Debt VS Equity VS FCFPODD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 3.58 indicates that PODD has no problem at all paying its short term obligations.
PODD's Current ratio of 3.58 is fine compared to the rest of the industry. PODD outperforms 63.68% of its industry peers.
PODD has a Quick Ratio of 2.76. This indicates that PODD is financially healthy and has no problem in meeting its short term obligations.
PODD's Quick ratio of 2.76 is fine compared to the rest of the industry. PODD outperforms 63.16% of its industry peers.
Industry RankSector Rank
Current Ratio 3.58
Quick Ratio 2.76
PODD Yearly Current Assets VS Current LiabilitesPODD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.43% over the past year.
The Earnings Per Share has been growing by 79.24% on average over the past years. This is a very strong growth
The Revenue has grown by 22.07% in the past year. This is a very strong growth!
Measured over the past years, PODD shows a very strong growth in Revenue. The Revenue has been growing by 22.92% on average per year.
EPS 1Y (TTM)22.43%
EPS 3Y58.9%
EPS 5Y79.24%
EPS Q2Q%-17.86%
Revenue 1Y (TTM)22.07%
Revenue growth 3Y23.54%
Revenue growth 5Y22.92%
Sales Q2Q%17.2%

3.2 Future

PODD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.57% yearly.
PODD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.04% yearly.
EPS Next Y29.15%
EPS Next 2Y26.03%
EPS Next 3Y23.51%
EPS Next 5Y20.57%
Revenue Next Year19.07%
Revenue Next 2Y18.25%
Revenue Next 3Y17.35%
Revenue Next 5Y15.04%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PODD Yearly Revenue VS EstimatesPODD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B 5B
PODD Yearly EPS VS EstimatesPODD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

PODD is valuated quite expensively with a Price/Earnings ratio of 74.11.
Based on the Price/Earnings ratio, PODD is valued a bit cheaper than the industry average as 66.32% of the companies are valued more expensively.
PODD is valuated expensively when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
PODD is valuated quite expensively with a Price/Forward Earnings ratio of 57.39.
70.00% of the companies in the same industry are more expensive than PODD, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.08, PODD is valued quite expensively.
Industry RankSector Rank
PE 74.11
Fwd PE 57.39
PODD Price Earnings VS Forward Price EarningsPODD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

67.37% of the companies in the same industry are more expensive than PODD, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, PODD is valued a bit cheaper than the industry average as 71.58% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 58.5
EV/EBITDA 45.57
PODD Per share dataPODD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of PODD may justify a higher PE ratio.
A more expensive valuation may be justified as PODD's earnings are expected to grow with 23.51% in the coming years.
PEG (NY)2.54
PEG (5Y)0.94
EPS Next 2Y26.03%
EPS Next 3Y23.51%

0

5. Dividend

5.1 Amount

PODD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INSULET CORP

NASDAQ:PODD (4/17/2025, 8:00:00 PM)

After market: 247 +0.2 (+0.08%)

246.8

-3.93 (-1.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)05-08 2025-05-08/amc
Inst Owners102.12%
Inst Owner Change0%
Ins Owners0.24%
Ins Owner Change1.98%
Market Cap17.33B
Analysts84.52
Price Target323.45 (31.06%)
Short Float %4.13%
Short Ratio4.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.95%
Min EPS beat(2)10.04%
Max EPS beat(2)15.85%
EPS beat(4)3
Avg EPS beat(4)26.52%
Min EPS beat(4)-4.04%
Max EPS beat(4)84.22%
EPS beat(8)7
Avg EPS beat(8)55.15%
EPS beat(12)10
Avg EPS beat(12)27.43%
EPS beat(16)12
Avg EPS beat(16)19.01%
Revenue beat(2)2
Avg Revenue beat(2)1.62%
Min Revenue beat(2)0.51%
Max Revenue beat(2)2.74%
Revenue beat(4)4
Avg Revenue beat(4)2.2%
Min Revenue beat(4)0.51%
Max Revenue beat(4)3.42%
Revenue beat(8)8
Avg Revenue beat(8)3.33%
Revenue beat(12)12
Avg Revenue beat(12)3.71%
Revenue beat(16)14
Avg Revenue beat(16)2.71%
PT rev (1m)0.33%
PT rev (3m)10.14%
EPS NQ rev (1m)-0.07%
EPS NQ rev (3m)4.76%
EPS NY rev (1m)8.56%
EPS NY rev (3m)8.59%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-0.09%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)0.85%
Valuation
Industry RankSector Rank
PE 74.11
Fwd PE 57.39
P/S 8.37
P/FCF 58.5
P/OCF 40.28
P/B 14.31
P/tB 16.33
EV/EBITDA 45.57
EPS(TTM)3.33
EY1.35%
EPS(NY)4.3
Fwd EY1.74%
FCF(TTM)4.22
FCFY1.71%
OCF(TTM)6.13
OCFY2.48%
SpS29.5
BVpS17.25
TBVpS15.12
PEG (NY)2.54
PEG (5Y)0.94
Profitability
Industry RankSector Rank
ROA 13.55%
ROE 34.52%
ROCE 12.07%
ROIC 9.49%
ROICexc 15.08%
ROICexgc 16.62%
OM 14.91%
PM (TTM) 20.19%
GM 69.79%
FCFM 14.3%
ROA(3y)7.24%
ROA(5y)4.58%
ROE(3y)21.22%
ROE(5y)13.56%
ROIC(3y)6.4%
ROIC(5y)5.42%
ROICexc(3y)9.71%
ROICexc(5y)8.89%
ROICexgc(3y)10.75%
ROICexgc(5y)9.79%
ROCE(3y)8.12%
ROCE(5y)6.87%
ROICexcg growth 3Y16.78%
ROICexcg growth 5Y18.66%
ROICexc growth 3Y15.99%
ROICexc growth 5Y18.5%
OM growth 3Y9.15%
OM growth 5Y17.1%
PM growth 3Y136.37%
PM growth 5Y66.64%
GM growth 3Y0.65%
GM growth 5Y1.41%
F-Score8
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 4.7
Debt/EBITDA 3.36
Cap/Depr 165.84%
Cap/Sales 6.47%
Interest Coverage 6.56
Cash Conversion 110.42%
Profit Quality 70.83%
Current Ratio 3.58
Quick Ratio 2.76
Altman-Z 7.09
F-Score8
WACC8.71%
ROIC/WACC1.09
Cap/Depr(3y)188.25%
Cap/Depr(5y)215.81%
Cap/Sales(3y)8.32%
Cap/Sales(5y)10.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.43%
EPS 3Y58.9%
EPS 5Y79.24%
EPS Q2Q%-17.86%
EPS Next Y29.15%
EPS Next 2Y26.03%
EPS Next 3Y23.51%
EPS Next 5Y20.57%
Revenue 1Y (TTM)22.07%
Revenue growth 3Y23.54%
Revenue growth 5Y22.92%
Sales Q2Q%17.2%
Revenue Next Year19.07%
Revenue Next 2Y18.25%
Revenue Next 3Y17.35%
Revenue Next 5Y15.04%
EBIT growth 1Y40.41%
EBIT growth 3Y34.84%
EBIT growth 5Y43.94%
EBIT Next Year79.29%
EBIT Next 3Y37.9%
EBIT Next 5Y30.34%
FCF growth 1Y711.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y195.33%
OCF growth 3YN/A
OCF growth 5Y34.32%